PositiveID (PSID) Partners With Wireless Technology Leaders at Connected Development to Complete Final Development of iglucose

DELRAY BEACH, Fla., Feb. 15, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID") (Nasdaq:PSID), a leader in next generation patient monitoring and diagnostics, announced today it has partnered with Connected Development to complete the final stage of development of its iglucose™ product. PositiveID's iglucose is a wireless communication device for the automatic transmission of blood glucose readings from any data-capable glucometer to the iglucose database. It functions without the use of a cellular telephone, telephone line or personal computer. PositiveID expects to complete the design and development of the iglucose product in March 2011, and submit it to the U.S. Food and Drug Administration for 510(k) clearance shortly thereafter.